BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 7459859)

  • 41. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.
    Dattoli M; Wallner K; True L; Cash J; Sorace R
    Cancer; 2003 Feb; 97(4):979-83. PubMed ID: 12569596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunologic-enzymatic determination of prostatic acid phosphatase in human serum].
    Heil W; Rick W; Golitz B
    Internist (Berl); 1985 Aug; 26(8):523-7. PubMed ID: 3902709
    [No Abstract]   [Full Text] [Related]  

  • 44. Alteration of acid phosphatase isoenzyme in a human prostatic cancer cell line.
    Lin CT; Liu JW; Wu JY; Dang H; Li CY; Lam KW
    Lab Invest; 1986 Dec; 55(6):666-72. PubMed ID: 3784536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Tumor markers in prostate cancer].
    Kuriyama M
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1915-22. PubMed ID: 7521999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prostatic acid phosphatase measured by immunoenzyme assay].
    Fuse H; Zama S; Shimazaki J
    Hinyokika Kiyo; 1985 Nov; 31(11):1957-64. PubMed ID: 2418660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The acid phosphatase isoenzymes in normal and pathological sera and in tissue homogenates.
    Rozenszajn L; Epstein Y; Shoham D; Arber I
    J Lab Clin Med; 1968 Nov; 72(5):786-93. PubMed ID: 5697388
    [No Abstract]   [Full Text] [Related]  

  • 48. Rapid radioimmunoassay for prostate-specific acid phosphatase in human serum.
    Vihko P; Kostama A; Jänne O; Sajanti E; Vihko R
    Clin Chem; 1980 Oct; 26(11):1544-7. PubMed ID: 6158382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
    Tarle M
    Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
    Tarle M; Kraljić I
    Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoreactive prostate-specific acid phosphatase in prostatic cancer.
    Kontturi M; Vihko P; Lukkarinen O; Vihko R
    Scand J Clin Lab Invest Suppl; 1985; 179():67-74. PubMed ID: 3866311
    [No Abstract]   [Full Text] [Related]  

  • 52. [Bone marrow acid phosphatase determination in patients with carcinoma of the prostate (author's transl)].
    Petritsch PH; Hubmer G
    Wien Klin Wochenschr; 1977 Nov; 89(22):765-8. PubMed ID: 930105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase.
    Lin MF; Meng TC
    Biochem Biophys Res Commun; 1996 Sep; 226(1):206-13. PubMed ID: 8806615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laboratory assessment of prostate status.
    Saito Y
    Clin Lab Med; 1993 Mar; 13(1):279-86. PubMed ID: 7681740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostatic acid phosphatase by radioimmunoassay. Sensitivity compared with enzymatic assay.
    Lindholm GR; Stirton S; Liedtke RJ; Batjer JD
    JAMA; 1980 Nov; 244(18):2071-3. PubMed ID: 6159488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cationic liposome-mediated incorporation of prostatic acid phosphatase protein into human prostate carcinoma cells.
    Lin MF; DaVolio J; Garcia R
    Biochem Biophys Res Commun; 1993 Apr; 192(2):413-9. PubMed ID: 7683459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical and immunological relationships of prostatic and leukocytic acid phosphatases and their subcellular localization.
    Zwirner A; Seitz J; Aumüller G
    Acta Biochim Pol; 1986; 33(2):127-31. PubMed ID: 2429487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Enzymological study of prostatic cancer. II. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase activity and lactic dehydrogenase isoenzymes in prostatic cancer, with special reference to relation with stage and histological malignancy].
    Ishibe T; Nihira H; Mori K
    Hinyokika Kiyo; 1969 Apr; 15(4):254-65. PubMed ID: 5817349
    [No Abstract]   [Full Text] [Related]  

  • 60. Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study.
    Fair WR; Heston WD; Kadmon D; Crane DB; Catalona WJ; Ladenson JH; McDonald JM; Noll BW; Harvey G
    J Urol; 1982 Oct; 128(4):735-8. PubMed ID: 6183457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.